reviewNature Reviews Clinical OncologyJun 30, 2015Closed access

ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer

RJRinath JeselsohnGBGilles BuchwalterCDCarmine De AngelisMBMyles BrownRSRachel Schiff

Harvard University · Dana-Farber Cancer Institute

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

678
total citations
FWCI
35.38
Percentile
100%
References
114
Citations per year

Authors

5

Topics & keywords

Topics
Keywords
  • Endocrine system
  • Tamoxifen
  • Breast cancer
  • Medicine
  • Metastatic breast cancer
  • Aromatase
  • Cancer research
  • Oncology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.